Y Intercept (Hong Kong) LTD Verona Pharma PLC Transaction History
Y Intercept (Hong Kong) LTD
- $3.75 Billion
- Q2 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Verona Pharma PLC stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 68,356 shares of VRNA stock, worth $7.2 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
68,356
Previous 11,350
502.26%
Holding current value
$7.2 Million
Previous $720,000
797.92%
% of portfolio
0.17%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding VRNA
# of Institutions
296Shares Held
73.5MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$692 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$581 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$414 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$364 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$305 Million3.9% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.42B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...